Aarhus University Seal / Aarhus Universitets segl

Spinouts

Spinouts fra Aarhus Universitet Technology Transfer Office

  

EtableretNavnBeskrivelse
2018Plantcarb ApS

Plantcarb ApS is a plant biotechnological spin-out from Aarhus University and University of Copenhagen established by (among others) two scientists who - as the only ones in the world - have developed a method for producing agricultural crops whose starch consists of 100% amylose. Starch is composed of two kinds of molecules. One type branches off and is called amylopectin (~ 75%). The other does not branch out and is called amylose. The two forms have very different properties. Unlike amylopectin, amylose does not dissolve in the stomach for sugar. Amylose therefore prevents type-2 diabetes. And unlike amylopectin, amylose is an excellent raw material for compostable bioplastics. Plantcarb focuses on both food and industry. For food, a 100% amylose crop (HIAMBA®) is developed to be used for flour for bread. For industrial use, a variant of 100% amylose maize is bred.

2018VPCIR.COM ApS

VPCIR.COM ApS is a biotechnological spin-out of Aarhus University and the Chinese University of Hong Kong. The company is founded by four researchers who together have invented a new and better laboratory method to detect disease-causing bacteria in food. The method - Viability Polymerase Circle Reaction, or VPCIR - is patent pending and utilizes the fact that the composition of certain enzymes in the bacterial cell constitutes a unique fingerprint. The VPCIR method is inexpensive, very sensitive and fast, easy to use, and therefore convenient in a laboratory. VPCIR is therefore a very competitive alternative to current methods.

2018STipe Therapeutics ApS

STipe Therapeutics focuses on enhancing long-term anti-cancer response by activating both innate and adaptive immunity, through a unique sensitizing technology targeting the STING pathway. The company has developed First-in-Class drugs that exploits and strengthens the STING pathway response to combat cancer, by increasing the innate immune response within the tumor microenvironment. Due to a unique sensitizing technology, it grants for a highly desirable systemic administration, which supports tumor growth inhibition and limited systemic inflammatory response. In September 2019 STipe received EUR 20 million in financing.

www.stipetherapeutics.com

 

2017Draupnir Bio ApSDraupnir Bio has developed a platform for exploring the glycome to develop novel therapeutics. The platform is based on array technology, protein chemistry and advanced carbohydrate chemistry. Our lead program focuses on the development of glycan mimetics for treatment of cardiovascular diseases.

2016Methyl Detect ApS 

Methyl Detect provides the solution to fast and sensitive detection of DNA methylation status of specific regions in the genome. We have ready – to - use kits available for a growing number of specific genes implicated in cancer development and progression. The analyses can be performed using standard laboratory equipment, and hereby, making Methyl Detect products easy to use and fast to interpret the results.  

www.methyldetect.com | Methyl Detect presentation film

2015Aarhus GeoSoftware 

Aarhus GeoSoftware is a leading provider of software for processing and inversion of geophysical data. We have developed a common platform where data handling is integrated from raw data to processing, inversion, quality check and visualization of results.  

www.aarhusgeosoftware.dk

2014RadiSurf ApS 

RadiSurf arbejder med en unik teknologi til at "lime" plast- og metalemner sammen i en meget tæt sammenføjning. Med et vedhæftningslag på under 100 nanometer skabes et ultra tæt interface, der alligevel er ekstremt stærkt. Et så tæt interface kombineret med styrken af samlingen giver unikke muligheder for metal/plast kombinationer i udstyr med særlige hygiejnekrav, unique designs, medico devices og mange andre steder. 

www.radisurf.com

2014VisBlue ApS 

VisBlue er en professionel partner indenfor lagring af bæredygtig energi. Via et skalerbart flowbatteri hjælper virksomheden kunder med at lagre solenergi effektivt, billigt og sikkert.

www.visblue.eu | Visbue presentation film

2005FBC Device ApS 

FBC Device er gået ind det kliniske udviklingsstadie. Virksomhedens resultater er opnået ved hjælp af et striks forretningsfokus på IP-rettigheder, produktudvikling og klinisk dokumentation for at kommercialisere rygimplantater, der har potentialet til at forbedre de kliniske resultater. Vi understøttes af et velrenommeret leverandørnetværk til at kontrollere omkostninger og kunne agere behændigt. Alt sammen som konsekvens af virksomhedens brede erfaring og netværk inden for rygkirurgi, klinisk forskning, implantatudvikling, marketing og kommercialisering.

www.fbcdevice.com